Back to Authors

Vazquez-Ramos, Carla A

Mayo Clinic

Department of Neurosurgery , Mayo Clinic , Jacksonville , Florida 32224 , United States.

Citations 2

Melatonin Treatment Triggers Metabolic and Intracellular pH Imbalance in Glioblastoma
Fernández-Gil, Beatriz I. , Otamendi-Lopez, Andrea, Bechtle, Alexandra , Vazquez-Ramos, Carla , Qosja, Neda, Suárez-Meade, Paola , Jentoft, Mark E. , Guerrero‐Cazares, Hugo , Escames, Germaine , Quiñones‐Hinojosa, Alfredo , Vazquez-Ramos, Carla A, Guerrero-Cazares, Hugo , Escames, Germaine , Schiapparelli, Paula , Sarabia-Estrada, Rachel

Cells | November 3, 2022 | Volume: 11 | Issue: 21 | Pages: 3467

10.3390/cells11213467 Get It

Metabolic rewiring in glioblastoma (GBM) is linked to intra- and extracellular pH regulation. In this study, we sought to characterize the role of melatonin on intracellular pH modulation and metabolic consequences to identify the mechanisms of action underlying melatonin oncostatic effects on GBM tumor initiating cells. GBM tumor initiating cells were treated at different times with melatonin (1.5 and 3.0 mM). We analyzed melatonin’s functional effects on GBM proliferation, cell cycle, viability, stemness, and chemo-radiosensitivity. We then assessed the effects of melatonin on GBM metabolism by analyzing the mitochondrial and glycolytic parameters. We also measured the intracellular and extracellular pH. Finally, we tested the effects of melatonin on a mouse subcutaneous xenograft model. We found that melatonin downregulated LDHA and MCT4, decreasing lactate production and inducing a decrease in intracellular pH that was associated with an increase in ROS and ATP depletion. These changes blocked cell cycle progression and induced cellular death and we observed similar results in vivo. Melatonin’s cytotoxic effects on GBM were due, at least in part, to intracellular pH modulation, which has emerged as a newly identified mechanism, providing new insights into the oncostatic effect of melatonin on GBM.
Verteporfin-Loaded Polymeric Microparticles for Intratumoral Treatment of Brain Cancer
Shah, Sagar , Schiapparelli, Paula , Vazquez-Ramos, Carla , Ruiz‐Valls, Alejandro , Inman, Kyle, Shamul, James G., Green, Jordan J. , Quiñones‐Hinojosa, Alfredo , Shah, Sagar R , Vazquez-Ramos, Carla A, Green, Jordan J , Kim, Jayoung , Martinez-Gutierrez, Juan Carlos , Inman, Kyle W

Molecular Pharmaceutics | February 26, 2019 | Volume: 16 | Issue: 4 | Pages: 1433-1443

10.1021/acs.molpharmaceut.8b00959 Get It